Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
The New Zealand Medical Journal
|
January 27, 1988
Atrial natriuretic factor and the heart in health and disease
M G Nicholls, H Ikram, E A Eppiner, et al.
Journal of Hypertension
|
April 1, 1993
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II
A M Richards, G A Wittert, I G Crozier, et al.
The American Journal of Cardiology
|
June 15, 1994
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study)
S G Foy, I G Crozier, J G Turner, et al.
Lancet (London, England)
|
April 7, 1984
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
Clinical and Experimental Pharmacology & Physiology
|
July 1, 1984
Moderate sodium restriction and potassium supplementation in essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
Postgraduate Medical Journal
|
April 1, 1973
Proceedings: Clinical evaluation of perhexiline maleate in patients with angina pectoris
H Ikram, K P Chandrasekhar, J Pilcher, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1985
Effects of alpha-human atrial natriuretic peptide in essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
European Heart Journal
|
June 1, 1995
Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition
S G Foy, I G Crozier, A M Richards, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure
A M Richards, I G Crozier, E A Espiner, et al.
Circulation
|
February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group
I Crozier, H Ikram, N Awan, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
The New Zealand Medical Journal
|
January 27, 1988
Atrial natriuretic factor and the heart in health and disease
M G Nicholls, H Ikram, E A Eppiner, et al.
Journal of Hypertension
|
April 1, 1993
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II
A M Richards, G A Wittert, I G Crozier, et al.
The American Journal of Cardiology
|
June 15, 1994
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study)
S G Foy, I G Crozier, J G Turner, et al.
Lancet (London, England)
|
April 7, 1984
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
Clinical and Experimental Pharmacology & Physiology
|
July 1, 1984
Moderate sodium restriction and potassium supplementation in essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
Postgraduate Medical Journal
|
April 1, 1973
Proceedings: Clinical evaluation of perhexiline maleate in patients with angina pectoris
H Ikram, K P Chandrasekhar, J Pilcher, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1985
Effects of alpha-human atrial natriuretic peptide in essential hypertension
A M Richards, M G Nicholls, E A Espiner, et al.
European Heart Journal
|
June 1, 1995
Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition
S G Foy, I G Crozier, A M Richards, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure
A M Richards, I G Crozier, E A Espiner, et al.
Circulation
|
February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group
I Crozier, H Ikram, N Awan, et al.
Page
of 23